Filtros : "HU-SCENFCP-62" "IBIDI, SILVIA MARIA" Limpar

Filtros



Refine with date range


  • Source: Pediatric Infectious Disease Journal. Unidade: HU

    Subjects: CANDIDÍASE, RECÉM-NASCIDO, MEDICAMENTO, PLACEBOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      HSIN, Shieh Huei e IBIDI, Silvia Maria e GILIO, Alfredo Elias. Number needed to treat in fluconazole prophylaxis in the neonatal intensive care unit [letter]. Pediatric Infectious Disease Journal. Baltimore: Hospital Universitário, Universidade de São Paulo. Disponível em: https://doi.org/10.1097/INF.0b013e3182140a6a. Acesso em: 30 set. 2024. , 2011
    • APA

      Hsin, S. H., Ibidi, S. M., & Gilio, A. E. (2011). Number needed to treat in fluconazole prophylaxis in the neonatal intensive care unit [letter]. Pediatric Infectious Disease Journal. Baltimore: Hospital Universitário, Universidade de São Paulo. doi:10.1097/INF.0b013e3182140a6a
    • NLM

      Hsin SH, Ibidi SM, Gilio AE. Number needed to treat in fluconazole prophylaxis in the neonatal intensive care unit [letter] [Internet]. Pediatric Infectious Disease Journal. 2011 ; 30( 5): 449.[citado 2024 set. 30 ] Available from: https://doi.org/10.1097/INF.0b013e3182140a6a
    • Vancouver

      Hsin SH, Ibidi SM, Gilio AE. Number needed to treat in fluconazole prophylaxis in the neonatal intensive care unit [letter] [Internet]. Pediatric Infectious Disease Journal. 2011 ; 30( 5): 449.[citado 2024 set. 30 ] Available from: https://doi.org/10.1097/INF.0b013e3182140a6a
  • Source: Pediatric Critical Care Medicine. Unidade: HU

    Subjects: SEPSE, RECÉM-NASCIDO, TRANSTORNOS HEMORRÁGICOS, FÁRMACOS (EFEITOS ADVERSOS)

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      HSIN, Shieh Huei et al. Comparison of main trials of recombinant human activated protein C in sepsis: are we encouraging more bleeding in neonates? [letter]. Pediatric Critical Care Medicine. Baltimore: Hospital Universitário, Universidade de São Paulo. Disponível em: https://doi.org/10.1097/PCC.0b013e3181e28c12. Acesso em: 30 set. 2024. , 2010
    • APA

      Hsin, S. H., Barreira, E. R., Goes, P. F., Bousso, A., Ventura, G. A. B., Melo, A. M. A. G. P. de, & Ibidi, S. M. (2010). Comparison of main trials of recombinant human activated protein C in sepsis: are we encouraging more bleeding in neonates? [letter]. Pediatric Critical Care Medicine. Baltimore: Hospital Universitário, Universidade de São Paulo. doi:10.1097/PCC.0b013e3181e28c12
    • NLM

      Hsin SH, Barreira ER, Goes PF, Bousso A, Ventura GAB, Melo AMAGP de, Ibidi SM. Comparison of main trials of recombinant human activated protein C in sepsis: are we encouraging more bleeding in neonates? [letter] [Internet]. Pediatric Critical Care Medicine. 2010 ; 11( 6): 767-768.[citado 2024 set. 30 ] Available from: https://doi.org/10.1097/PCC.0b013e3181e28c12
    • Vancouver

      Hsin SH, Barreira ER, Goes PF, Bousso A, Ventura GAB, Melo AMAGP de, Ibidi SM. Comparison of main trials of recombinant human activated protein C in sepsis: are we encouraging more bleeding in neonates? [letter] [Internet]. Pediatric Critical Care Medicine. 2010 ; 11( 6): 767-768.[citado 2024 set. 30 ] Available from: https://doi.org/10.1097/PCC.0b013e3181e28c12

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024